Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Tonix Pharmaceuticals Holding (TNXP) Receivables - Net (2023 - 2025)

Tonix Pharmaceuticals Holding has reported Receivables - Net over the past 3 years, most recently at $6.3 million for Q4 2025.

  • Quarterly results put Receivables - Net at $6.3 million for Q4 2025, up 70.27% from a year ago — trailing twelve months through Dec 2025 was $6.3 million (up 70.27% YoY), and the annual figure for FY2025 was $6.3 million, up 70.27%.
  • Receivables - Net for Q4 2025 was $6.3 million at Tonix Pharmaceuticals Holding, up from $3.5 million in the prior quarter.
  • Over the last five years, Receivables - Net for TNXP hit a ceiling of $6.3 million in Q4 2025 and a floor of $1.6 million in Q3 2023.
  • Median Receivables - Net over the past 3 years was $3.5 million (2025), compared with a mean of $3.6 million.
  • Biggest five-year swings in Receivables - Net: skyrocketed 156.91% in 2024 and later crashed 30.52% in 2025.
  • Tonix Pharmaceuticals Holding's Receivables - Net stood at $4.6 million in 2023, then decreased by 19.76% to $3.7 million in 2024, then skyrocketed by 70.27% to $6.3 million in 2025.
  • The last three reported values for Receivables - Net were $6.3 million (Q4 2025), $3.5 million (Q3 2025), and $2.3 million (Q2 2025) per Business Quant data.